| Challenges and opportunities in dermal/transdermal delivery KS Paudel, M Milewski, CL Swadley, NK Brogden, P Ghosh, ... Therapeutic delivery 1 (1), 109-131, 2010 | 657 | 2010 |
| Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis DC Hammell, LP Zhang, F Ma, SM Abshire, SL McIlwrath, AL Stinchcomb, ... European journal of pain 20 (6), 936-948, 2016 | 402 | 2016 |
| Microneedles permit transdermal delivery of a skin-impermeant medication to humans DP Wermeling, SL Banks, DA Hudson, HS Gill, J Gupta, MR Prausnitz, ... Proceedings of the National Academy of Sciences 105 (6), 2058-2063, 2008 | 353 | 2008 |
| Characterization of the permeability barrier of human skin in vivo F Pirot, YN Kalia, AL Stinchcomb, G Keating, A Bunge, RH Guy Proceedings of the National Academy of Sciences 94 (4), 1562-1567, 1997 | 247 | 1997 |
| Human skin permeation of Δ8‐tetrahydrocannabinol, cannabidiol and cannabinol AL Stinchcomb, S Valiveti, DC Hammell, DR Ramsey Journal of pharmacy and pharmacology 56 (3), 291-297, 2004 | 162 | 2004 |
| Programmable transdermal drug delivery of nicotine using carbon nanotube membranes J Wu, KS Paudel, C Strasinger, D Hammell, AL Stinchcomb, BJ Hinds Proceedings of the National Academy of Sciences 107 (26), 11698-11702, 2010 | 152 | 2010 |
| Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle G Gonzalez-Cuevas, R Martin-Fardon, TM Kerr, DG Stouffer, LH Parsons, ... Neuropsychopharmacology 43 (10), 2036-2045, 2018 | 142 | 2018 |
| Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers KS Paudel, DC Hammell, RU Agu, S Valiveti, AL Stinchcomb Drug development and industrial pharmacy 36 (9), 1088-1097, 2010 | 133 | 2010 |
| Use of cannabidiol prodrugs in topical and transdermal administration with microneedles AL Stinchcomb, SL Banks, MJ Golinski, JL Howard, DC Hammell US Patent App. 12/873,248, 2011 | 125 | 2011 |
| Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same AL Stinchcomb, SL Banks US Patent App. 12/769,519, 2010 | 124 | 2010 |
| Determining dermal absorption parameters in vivo from tape strip data MB Reddy, AL Stinchcomb, RH Guy, AL Bunge Pharmaceutical research 19, 292-298, 2002 | 106 | 2002 |
| In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation PVN Challapalli, AL Stinchcomb International journal of pharmaceutics 241 (2), 329-339, 2002 | 105 | 2002 |
| Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents AL Stinchcomb, F Pirot, GD Touraille, AL Bunge, RH Guy Pharmaceutical research 16, 1288-1293, 1999 | 98 | 1999 |
| Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same AL Stinchcomb, MJ Golinski, DC Hammell, JL Howard, SL Banks US Patent 8,293,786, 2012 | 96 | 2012 |
| Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin AL Stinchcomb, PW Swaan, O Ekabo, KK Harris, J Browe, DC Hammell, ... Journal of pharmaceutical sciences 91 (12), 2571-2578, 2002 | 96 | 2002 |
| Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis (hydroxy-methyl) propionyl-3-0 ester naltrexone using microneedles A Stinchcomb, S Banks, R Pinninti US Patent App. 11/812,249, 2008 | 86 | 2008 |
| Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin M Milewski, NK Brogden, AL Stinchcomb Expert opinion on drug delivery 7 (5), 617-629, 2010 | 85 | 2010 |
| Diclofenac delays micropore closure following microneedle treatment in human subjects NK Brogden, M Milewski, P Ghosh, L Hardi, LJ Crofford, AL Stinchcomb Journal of controlled release 163 (2), 220-229, 2012 | 79 | 2012 |
| Cannabinoid-Containing Compositions and Methods for Their Use AL Stinchcomb, SL Banks US Patent App. 13/318,208, 2012 | 79 | 2012 |
| Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs SL Banks, RR Pinninti, HS Gill, KS Paudel, PA Crooks, NK Brogden, ... Journal of pharmaceutical sciences 99 (7), 3072-3080, 2010 | 79 | 2010 |
